Morgan Stanley’s Regencell Bioscience RGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $563K | Buy |
33,020
+33,015
| +660,300% | +$563K | ﹤0.01% | 5413 |
|
|
2025
Q1 | $159 | Sell |
5
-2,095
| -100% | -$66.6K | ﹤0.01% | 7499 |
|
|
2024
Q4 | $10.4K | Buy |
+2,100
| New | +$10.4K | ﹤0.01% | 6787 |
|
|
2023
Q4 | – | Sell |
-326
| Closed | -$4.56K | – | 7894 |
|
|
2023
Q3 | $4.56K | Buy |
326
+25
| +8% | +$350 | ﹤0.01% | 6936 |
|
|
2023
Q2 | $6.53K | Buy |
301
+4
| +1% | +$87 | ﹤0.01% | 6923 |
|
|
2023
Q1 | $7.69K | Buy |
297
+16
| +6% | +$414 | ﹤0.01% | 6959 |
|
|
2022
Q4 | $7.64K | Buy |
281
+54
| +24% | +$1.47K | ﹤0.01% | 7029 |
|
|
2022
Q3 | $7K | Buy |
227
+78
| +52% | +$2.41K | ﹤0.01% | 7186 |
|
|
2022
Q2 | $5K | Buy |
149
+143
| +2,383% | +$4.8K | ﹤0.01% | 7406 |
|
|
2022
Q1 | $0 | Buy |
+6
| New | – | ﹤0.01% | 8089 |
|
|
2021
Q4 | – | Sell |
-503
| Closed | -$11K | – | 8088 |
|
|
2021
Q3 | $11K | Buy |
+503
| New | +$11K | ﹤0.01% | 7291 |
|